SABBY MANAGEMENT, LLC - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 22 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$500,000
-42.2%
1,085,446
+132.0%
0.14%
-70.2%
Q3 2019$865,000
-35.3%
467,819
-0.2%
0.47%
-72.3%
Q2 2019$1,336,000468,6201.68%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Yu Fan 89,848$66,0000.75%
Virtu Financial LLC 285,621$209,0000.02%
GSA CAPITAL PARTNERS LLP 30,180$22,0000.00%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 43,868$32,0000.00%
Hoover Financial Advisors, Inc. 4,225$3,0000.00%
Renaissance Technologies 1,375,579$1,004,0000.00%
Frontier Wealth Management LLC 25,000$18,0000.00%
UBS Group AG 36,910$27,0000.00%
IFP Advisors, Inc 0$00.00%
OSAIC HOLDINGS, INC. 29,569$22,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders